Completed NA INTERVENTIONAL 2-arm NCT06392672

Evaluation of the Effect of Drug-Related Problems in Pulmonary Embolism

Evaluation of the Effect of Management of Drug-Related Problems on Clinical Outcomes of Pulmonary Embolism Outpatients

Sponsor: Bezmialem Vakif University

Interventions Intervention Group: Group to which the clinical pharmacist makes recommendations

Updated 5 times since 2024 Last updated: Apr 29, 2024 Started: Jan 15, 2022 Primary completion: Jan 15, 2023 Completion: Jan 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06392672, this NA trial focuses on Pulmonary Thromboembolisms and remains completed. Sponsored by Bezmialem Vakif University, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Jan 2025 — Sep 2025 [monthly]

Completed NA
Sep 2024 — Jan 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bezmialem Vakif University
Istanbul Sultanbeyli State Hospital
Istanbul University - Cerrahpasa
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Data source: Bezmialem Vakif University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)